These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24996644)

  • 1. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.
    Wu J; Hao ZW; Zhao YX; Yang XM; Tang H; Zhang X; Song F; Sun XX; Wang B; Nan G; Chen ZN; Bian H
    J Transl Med; 2014 Jul; 12():190. PubMed ID: 24996644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
    Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
    Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.
    Xu HY; Qian AR; Shang P; Xu J; Kong LM; Bian HJ; Chen ZN
    Cancer Lett; 2007 Mar; 247(2):336-44. PubMed ID: 16815629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.
    Tang J; Wu YM; Zhao P; Yang XM; Jiang JL; Chen ZN
    Cell Mol Life Sci; 2008 Sep; 65(18):2933-42. PubMed ID: 18695939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells.
    Qian AR; Zhang W; Cao JP; Yang PF; Gao X; Wang Z; Xu HY; Weng YY; Shang P
    J Exp Clin Cancer Res; 2008 Oct; 27(1):50. PubMed ID: 18847500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
    Qian L; Liu Y; Xu Y; Ji W; Wu Q; Liu Y; Gao Q; Su C
    Cancer Lett; 2015 Nov; 368(1):126-134. PubMed ID: 26259512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle.
    Qi S; Su L; Li J; Zhao P; Zhang Q; Niu X; Liu J; Jia G; Wei X; Tavernier J; Jiang J; Chen Z; Zhang S
    Cell Death Dis; 2019 Jun; 10(6):462. PubMed ID: 31189879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation.
    Gou X; Ru Q; Zhang H; Chen Y; Li L; Yang H; Xing J; Chen Z
    Cancer Sci; 2009 May; 100(5):837-43. PubMed ID: 19298604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
    Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
    J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
    Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
    J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
    Wang Y; Yuan L; Yang XM; Wei D; Wang B; Sun XX; Feng F; Nan G; Wang Y; Chen ZN; Bian H
    Clin Exp Metastasis; 2015 Jan; 32(1):39-53. PubMed ID: 25424030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
    Zhang Q; Chen X; Zhou J; Zhang L; Zhao Q; Chen G; Xu J; Qian F; Chen Z
    Cancer Biol Ther; 2006 Jul; 5(7):808-14. PubMed ID: 16775432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
    Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
    J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.
    Zhang R; Pan X; Huang Z; Weber GF; Zhang G
    PLoS One; 2011; 6(8):e23831. PubMed ID: 21909361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
    Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
    Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.